QUANTUM BIOPHAR (QNTM)
(Delayed Data from NSDQ)
$5.54 USD
-0.12 (-2.19%)
Updated Oct 28, 2024 04:00 PM ET
After-Market: $5.50 -0.04 (-0.72%) 6:52 PM ET
2-Buy of 5 2
F Value A Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -2.78 |
EPS Last Quarter | -5.19 |
Last EPS Surprise | -33.33% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.27 |
Next Year | -1.54 |
EPS (TTM) | -12.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 0.95M | 0.95M | 8.68M |
# of Estimates | NA | 1 | 1 | 1 |
High Estimate | NA | 0.95M | 0.95M | 8.68M |
Low Estimate | NA | 0.95M | 0.95M | 8.68M |
Year ago Sales | 0.00M | 0.00M | NA | 0.95M |
Year over Year Growth Est. | NA | NA | NA | 813.68% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.78 | -0.80 | -3.27 | -1.54 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -2.78 | -0.80 | -3.27 | -1.54 |
High Estimate | -2.78 | -0.80 | -3.27 | -1.54 |
Low Estimate | -2.78 | -0.80 | -3.27 | -1.54 |
Year ago EPS | -1.95 | -2.60 | -29.87 | -3.27 |
Year over Year Growth Est. | -42.56% | 69.23% | 89.05% | 52.91% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.78 | -0.80 | -3.27 | -1.54 |
7 Days Ago | -2.78 | -0.80 | -3.27 | -1.54 |
30 Days Ago | -2.78 | -0.80 | -3.27 | -1.54 |
60 Days Ago | -3.90 | -3.25 | -14.29 | -7.79 |
90 Days Ago | -3.90 | -3.25 | -14.29 | -7.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.78 | -0.80 | -3.27 | -1.54 |
Zacks Consensus Estimate | -2.78 | -0.80 | -3.27 | -1.54 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -5.19 | -3.25 | -2.60 | -1.95 | NA |
Estimate | -3.90 | -3.25 | NA | NA | NA |
Difference | -1.29 | 0.00 | NA | NA | -0.65 |
Surprise | -33.33% | 0.00% | NA | NA | -16.67% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more